Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.1B | 5.3B | 5.2B | 5.1B |
Cost of revenue | 2.1B | 2.0B | 2.0B | 2.0B |
Gross profit | 3.1B | 3.2B | 3.2B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.7B | 1.6B | 1.6B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | 1.4B | 1.7B | 1.6B | 1.4B |
Non operating interest income | ||||
Income | 8M | 11M | 13M | 9M |
Expense | 339M | 334M | 339M | 294M |
Other income expense | 2M | -161M | -5M | -5M |
Pretax income | 1.0B | 1.2B | 1.3B | 1.1B |
Tax provision | 190M | 193M | 74M | 221M |
Net income | 848M | 948M | 571M | 909M |
Basic EPS | 1.5 | 1.7 | 1.0 | 1.5 |
Diluted EPS | 1.5 | 1.6 | 1.0 | 1.5 |
Basic average shares | 556M | 564M | 570M | 577M |
Diluted average shares | 564.7M | 571.4M | 576.9M | 585.4M |
EBITDA | 2.1B | 2.3B | 2.4B | 2.2B |
Net income from continuing op. | 848M | 948M | 571M | 909M |
Minority interests | 3M | -10M | -7M | -15M |
Preferred stock dividends | — | — | — | — |